Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > DEA Meetings & Events > Pharmacy Diversion Awareness Conference > June 22 & 23, 2013; Chicago, Illinois

Pharmacy Diversion Awareness Conference

June 22 & 23, 2013; Renaissance Schaumburg Convention Center Hotel; Chicago, Illinois

The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on June 22nd and 23rd, 2013 in Chicago, IL. This was a one-day conference, repeated on the second day for the convenience of the pharmacy community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.

Over 300 pharmacists, pharmacy technicians, and loss prevention personnel attended. The conference attendees received approximately seven hours of instruction on a variety of topics.

Below are some of the presentations from the Chicago PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure. More presentations will be added as they become available.

Drugs, Drugs, and More Drugs – William T. Winsley, R.Ph., National Association of Boards of Pharmacy Representative

Drug Theft Prevention – John Partridge, Executive Assistant, Office of Diversion Control

Pharmacy Robbery & Burglary Brochure

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility